Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cboe Global Markets (CBOE) EBT: 2010-2025

Historic EBT for Cboe Global Markets (CBOE) over the last 16 years, with Sep 2025 value amounting to $430.1 million.

  • Cboe Global Markets' EBT rose 39.19% to $430.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year increase of 27.76%. This contributed to the annual value of $1.1 billion for FY2024, which is 3.46% up from last year.
  • Latest data reveals that Cboe Global Markets reported EBT of $430.1 million as of Q3 2025, which was up 28.54% from $334.6 million recorded in Q2 2025.
  • In the past 5 years, Cboe Global Markets' EBT ranged from a high of $430.1 million in Q3 2025 and a low of -$256.8 million during Q2 2022.
  • In the last 3 years, Cboe Global Markets' EBT had a median value of $287.5 million in 2023 and averaged $295.1 million.
  • As far as peak fluctuations go, Cboe Global Markets' EBT slumped by 243.30% in 2022, and later spiked by 194.16% in 2023.
  • Quarterly analysis of 5 years shows Cboe Global Markets' EBT stood at $210.2 million in 2021, then grew by 12.18% to $235.8 million in 2022, then increased by 21.93% to $287.5 million in 2023, then decreased by 2.71% to $279.7 million in 2024, then spiked by 39.19% to $430.1 million in 2025.
  • Its EBT stands at $430.1 million for Q3 2025, versus $334.6 million for Q2 2025 and $350.2 million for Q1 2025.